Fig. 1.
Timeline of EMA-approved targeted therapies and the ESMO-recommendations for predictive biomarker testing associated with these targeted drugs for patients with advanced stage NSCLC (as of July 2023).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.